.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Army
Harvard Business School
Teva
US Department of Justice
Daiichi Sankyo
QuintilesIMS
Fish and Richardson
McKesson
McKinsey
Merck

Generated: November 18, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: GADOVERSETAMIDE

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937NDALiebel-Flarsheim Company LLC0019-1177-505 BOTTLE, GLASS in 1 CARTON (0019-1177-50) > 50 mL in 1 BOTTLE, GLASS
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937NDALiebel-Flarsheim Company LLC0019-1177-1110 SYRINGE, PLASTIC in 1 CARTON (0019-1177-11) > 10 mL in 1 SYRINGE, PLASTIC
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937NDALiebel-Flarsheim Company LLC0019-1177-1610 SYRINGE, PLASTIC in 1 CARTON (0019-1177-16) > 15 mL in 1 SYRINGE, PLASTIC
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937NDALiebel-Flarsheim Company LLC0019-1177-2110 SYRINGE, PLASTIC in 1 CARTON (0019-1177-21) > 20 mL in 1 SYRINGE, PLASTIC
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937NDALiebel-Flarsheim Company LLC0019-1177-3110 SYRINGE, PLASTIC in 1 CARTON (0019-1177-31) > 30 mL in 1 SYRINGE, PLASTIC
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937NDALiebel-Flarsheim Company LLC0019-1177-0210 VIAL, GLASS in 1 CARTON (0019-1177-02) > 5 mL in 1 VIAL, GLASS
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937NDALiebel-Flarsheim Company LLC0019-1177-0410 VIAL, GLASS in 1 CARTON (0019-1177-04) > 10 mL in 1 VIAL, GLASS
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937NDALiebel-Flarsheim Company LLC0019-1177-0610 VIAL, GLASS in 1 CARTON (0019-1177-06) > 15 mL in 1 VIAL, GLASS
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020937NDALiebel-Flarsheim Company LLC0019-1177-0810 VIAL, GLASS in 1 CARTON (0019-1177-08) > 20 mL in 1 VIAL, GLASS
Liebel-flarsheim
OPTIMARK
gadoversetamide
INJECTABLE;INJECTION020975NDALiebel-Flarsheim Company LLC0019-1177-505 BOTTLE, GLASS in 1 CARTON (0019-1177-50) > 50 mL in 1 BOTTLE, GLASS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
AstraZeneca
Teva
Novartis
Daiichi Sankyo
Fuji
Colorcon
Deloitte
Cantor Fitzgerald
Farmers Insurance

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot